NEWS & UPDATES
Project Farma Blog
Thought Leadership - 11.20.2024
Chevron Deference: A New Era for Biotech
Thought Leadership - 10.15.2024
Ori Biotech Podcast: Challenges & Opportunities in CGT
Thought Leadership - 09.18.2024
US Crackdown on Chinese Clinical Trials: What’s at Stake for Biopharma?
Thought Leadership - 09.13.2024
Will BIOSECURE Boost US Pharma?
Thought Leadership - 08.23.2024
The Bottom Line on Chevron’s Overturn
Thought Leadership - 07.18.2024
Perspectives on the Future of the BIOSECURE Act
Thought Leadership - 07.17.2024
Bracing for Impact of BIOSECURE Act
Thought Leadership - 04.24.2024
When Should Biopharma Companies Buy, Partner or Develop Innovative Assets?
Thought Leadership - 04.21.2024
Strategic Portfolio Management in Cell and Gene Therapy: Keys to Growth and Impact
Thought Leadership - 04.09.2024
Why Smaller M&A Deals Boost Biopharma Growth
